Charles River Labs is getting a wall of higher price targets after its analyst day — BofA, Jefferies, Morgan Stanley and JPMorgan among firms now clustered in a $260-to-low-$330s band, with a fresh fa

Analyst day target increases raise Charles River Laboratories fair value estimate.